Dry-eye syndrome treatment using intense pulsed light technology
is a device that generates a new type of polychromatic pulsed light by producing calibrated and homogenously sequenced light pulses. The idea here is that the energy spectrum and time periods are precisely set to stimulate the meibomian glands so that they return to their normal function.
Simple & fast
Session treatment only takes a few minutes.
You will be comfortably seated on a treatment chair. The ceramic eyewear protection shells are adjusted on your eyes. Then optical gel is applied on the cheekbone and the temporal areas.
A series of 5 flashes are applied under one eye, starting from the inner side out to the temple area, using the required power.
The same process is then repeated under the other eye.
The dry-eye syndrome is a common pathology affecting - depending on the areas - between 5 to 15% of the population with symptoms increasing with age. Conditions of a modern lifestyle (including working on computer screens, driving cars, artificial lights, air pollution, wearing eye contact lenses...) make dry-eye syndrome a more and more frequent nuisance.
Generally speaking, dry-eye conditions are a result of a lacrimal layer issue, either caused by insufficient tears or an excessive evaporation.
It is recognised that a large majority of cases are caused by the evaporation form, mainly due to an insufficiency of the external lipid layer of the lacrimal film secreted by the Meibomian glands.
The lacrimal film, necessary to the eye function, is made of 3 layers:
The mucous layer, in contact with the ocular globe, secreted by the conjonctival mucous cells.
The aqueous layer, secreted by lacrymal glands.
The lipid layer, secreted by meibomian glands.
There are 80 meibomian cells located on the upper and lower eyelids.
These cells produce a fat phase, avoiding tear evaporation, adapting the tears to the irrigularities of the eye surface and a perfectly convex dioptre.
Lipids are made of polarised fat acids. Their fluidity is ensured by the body temperature. They are non- polarised on the surface, giving the stability of the lacrymal fluid and allowing the lubrification of the palpebral conjonctival plan. The contraction of the Riolan muscle allows the lacrimal film to spread out.
Clinical studies have been conducted in France, New Zealand and China. These studies have shown:
- A considerable improvement in the symptoms perceived by patients with a 90% satisfaction rate on the first 2 treatments. This improvement has been acknowledged from the patient’s opinion about the discomfort levels before and after the treatment and the improvement of the fixation time while reading or watching television. This improvement is clearly felt from the initial session for the first couple of days and is increasing in time after the second and following treatments.
- A correlation between this perception and clinical measurement executed. 45% of patients originally classified as level 2 (Oxford classification) have, after instillation of fluoresceine, been improved by one or two levels. 81% of patients from level 1 have improved by 1 level.
We have obtained these remarkable results two months (on average) after the third treatment.
This non-invasive treatment, which is affordable with fast results, is a revolution in many ways.